ARCHIVES

CMS To Recognize NCCN’s Drug Compendium.

This article is from The Cancer Letter archive.

Vol. 34 No. 22 | June 6, 2008

Download PDF Visit The Full Archive

Related Articles

RG7204 Meets Endpoints Of Extending Survival, PFS

February 25, 2011

UCSF Gets $20 Million For Stem Cell Research Building

February 4, 2011

In Brief: fraud By Trainee Leads Collins To Retract Five Paper; Weinstein Retires At Columbia

November 1, 1996

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

In Brief: Thomas King Names Special Assistant To Lombardi Center Director; John MacDonald Takes U. Ky. Job

March 30, 1984

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999